Data from EMC - Curated by Toby Galbraith - Last updated 14 March 2017

Licensing authority

MHRA (Medicines and Healthcare products Regulatory Agency, UK)


Actikerall is indicated for the topical treatment of slightly palpable and/or moderately thick hyperkeratotic actinic keratosis (grade I/II) in immunocompetent adult patients.

Grade I/II intensity is based on the 4-point scale of Olsen et al. (1991).

Full Prescribing information

Learning Zones

An Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

Prostate Cancer

How can you balance the harmful effects of treatment with control of prostate cancer growth in otherwise healthy patients?

Visit Prostate Cancer

Type 2 Diabetes

View the latest epidemiology data, patient perspectives, ADA and EASD recommendations, treatment options and more

Visit Type 2 Diabetes

More information

Category Value
Authorisation number PL 33016/0015
Orphan designation No
Date First Approved 03-06-2011
Type POM
Marketing authorisation holder Almirall Hermal GmbH

Related Content